Carogen Corp
Advertisement
CaroGen Corporation, based in Hamden, CT, is a biotechnology firm focused on developing innovative immunotherapies, primarily utilizing their novel AVIDIO platform, which enables the delivery of multiple transgenes. The company is advancing two key candidates, CARG-201 for chronic hepatitis B and CARG-2020 for ovarian cancer, both currently in late-stage pre-clinical studies.
With a robust patent portfolio and significant financial backing, including over $16 million in grants from NIH and DoD, CaroGen aims to revolutionize treatment options in immuno-oncology and infectious diseases. The team is led by seasoned professionals with strong scientific backgrounds, committed to addressing critical health challenges through transformative therapies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
